ASTMH 2019

[National Harbor, Maryland, EUA, 20-24 novembro, 2019]

A reunião anual da Sociedade Americana de Medicina Tropical e Higiene (ASTMH) é destinada a pesquisadores, professores, médicos, estudantes e todos os profissionais de saúde que trabalham nas áreas de medicina tropical, higiene e saúde global.

Symposium

New tools to accelerate elimination of onchocerciasis

Date: Sunday, 24 November 2019
Time: 8:00-9:45
Room: National Harbor 11 (National Harbor Level)

Co-chairs: Sara Lustigman, Head of Molecular Parasitology Lab, NY Blood Center, USA and Annie Mo, NIAID, NIH, USA

Accelerating elimination of NTDs in AFRICA: Onchocerciasis
Maria Rebollo Polo, Head of ESPEN, WHO Africa, DRC

Macrofilaricidal drug development – onwards and upwards
Sabine Specht, Head Filarial Diseases, DNDi, Switzerland

Prophylactic vaccine and vaccine linked-chemotherapy to protect against new infections
Sara Lustigman, Head of Molecular Parasitology Lab, NY Blood Center, USA

Biomarkers for infections and success of elimination
Tom Nutman, NIAID, NIH, USA

Overview of resources available for transnational research
Annie Mo, NIAID, NIH, USA

Oral presentations

Date: Thursday, 21 November 2019
Time: 13:45-14:00
Room: National Harbor 11 (National Harbor Level)

Association of pre-control infection prevalence of lymphatic filariasis with clinical morbidity
Vinkeles Melchers NV*, Stolk WA , Pedrique B , Vanhommerig JW, Coffeng LE , de Vlas SJ

Date: Friday, 22 November 2019
Time: 14:15-14:30
Room: National Harbor 11 (National Harbor Level)

Drug development for the treatment and control of onchocerciasis: A population pharmacokinetic analysis of emodepside (BAY 44-4400) in healthy male
Assmus F*, Hoglund RM, Scandale I, Tarning J

Date: Friday, 22 November 2019
Time: 16:00-16:15
Room: National Harbor 2 (National Harbor Level)

Estimation of incidence rate of mortality for antileishmanial therapies: A systematic review of published literature from 1980 to 2018
Singh S*, Dahal P, Ngu R, Maguire B, Olliaro P, Stepniewska K, Halleux C, Alves F

Date: Sunday, 24 November 2019
Time: 11:55-12:15
Room: Potomac C (Ballroom Level)

DNDi: Clinical trials of repurposed drugs in novel combinations, doses and routes, and identification of new compounds
Nathalie Strub-Wourgaft, NTD Director, DNDi, Switzerland

Poster

Date: Saturday, 23 November 2019
Time: 12:00-13:45

Evaluating new regimens for the treatment of chronic Chagas disease: The BENDITA trial
Barreira F, Blum B, Garcia W, Gascón J, Ortiz L, Torrico F, Sosa-Estani S

Ajude os pacientes negligenciados

Até o momento, desenvolvemos nove tratamentos para doenças negligenciadas, salvando milhões de vidas. Temos o objetivo de disponibilizar 25 novos tratamentos em nossos primeiros 25 anos. Você pode nos ajudar!

Faça sua doação

Organização internacional, sem fins lucrativos, que desenvolve tratamentos seguros, eficazes e acessíveis para os pacientes mais negligenciados.

DNDi Global

Saiba mais

Doenças Nossos Projetos Advocacy

Entre em contato

DNDi pelo mundo

Apoie a DNDi

Faça uma doação!

Trabalhe conosco

Oportunidades

Exceto para imagens, filmes e marcas registradas que estão sujeitos aos Termos de Uso da DNDi, o conteúdo deste site está licenciado sob uma Licença Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License.